| Literature DB >> 8605891 |
S J Delaney1, E W Alton, S N Smith, D P Lunn, R Farley, P K Lovelock, S A Thomson, D A Hume, D Lamb, D J Porteous, J R Dorin, B J Wainwright.
Abstract
We have generated a mouse carrying the human G551D mutation in the cystic fibrosis transmembrane conductance regulator gene (CFTR) by a one-step gene targeting procedure. These mutant mice show cystic fibrosis pathology but have a reduced risk of fatal intestinal blockage compared with 'null' mutants, in keeping with the reduced incidence of meconium ileus in G551D patients. The G551D mutant mice show greatly reduced CFTR-related chloride transport, displaying activity intermediate between that of cftr(mlUNC) replacement ('null') and cftr(mlHGU) insertional (residual activity) mutants and equivalent to approximately 4% of wild-type CFTR activity. The long-term survival of these animals should provide an excellent model with which to study cystic fibrosis, and they illustrate the value of mouse models carrying relevant mutations for examining genotype-phenotype correlations.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8605891 PMCID: PMC449990
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598